Business Areas
State-of-the-art systems, products, solutions and services that combine user-friendliness, accessibility and cutting-edge capabilities to enable the proliferation of 3D cell culture with any cell line, in any geometry, using any biomaterial.
Facilitate faster and smarter workflows in multiomics, biopharma cell line development (CLD), combinatorial screenings and next-generation sequencing.
Accelerating the development and manufacturing of innovative, reliable, cost-efficient diagnostic and bioanalysis test platforms for the sake of patients, consumers, public health and the environment.
